Table 1

Baseline characteristics of the study population

PTA Group

MT Group

p

(n = 123)

(n = 113)


Age (yr)

64.7 ± 9.7

66.2 ± 8.9

0.323

Males

92 (74.8)

97 (85.8)

0.034

Risk factors

Hypercholesterolemia

98 (79.6)

79 (69.9)

0.152

Hypertension

112 (91.0)

183 (92.0)

0.757

Smoking

107 (87.0)

91 (80.5)

0.239

BMI

27.6 ± 5.3

26.5 ± 5.2

0.831

LE-PAD severity

ABI

0.66 ± 0.18

0.65 ± 0.17

0.580

MWD (meters)

108.7 ± 300.9

378.4 ± 552.3

0.001

Comorbidity

Previous MI

32 (26.0)

33 (29.2)

0.584

Previous stroke

3 (2.4)

1 (0.9)

0.360

Inflammatory status

Leukocyte count (x 109/L)

7.9 [6.6 – 9.3]

7.4 [5.9 – 9.1]

0.150


Values are n (%) or mean ± SD or median [interquartile range].

PTA = percutaneous transluminal angioplasty; MT = medical therapy; BMI = body mass index; LE-PAD = lower extremity peripheral arterial disease; ABI = ankle/brachial index; MWD = maximum walking distance; MI = myocardial infarction.

Giugliano et al. BMC Surgery 2012 12(Suppl 1):S19   doi:10.1186/1471-2482-12-S1-S19

Open Data